Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02355262 · ClinicalTrials.gov registry record

CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers

A clinical trial, sponsored by OHSU Knight Cancer Institute.

Completed
Registry status
45
Enrollment target

NCT02355262: Completed study, sponsored by OHSU Knight Cancer Institute.

NCT02355262 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02355262 has completed, sponsored by OHSU Knight Cancer Institute.

COMPLETED
Registry status
45 participants
Enrollment target

Study Summary

This randomized research trial studies the Community-based Health Information Technology (HIT) Tools for Cancer Screening and Health Insurance Promotion (CATCH-UP) intervention in increasing cancer screening and prevention care in uninsured patients at community health centers. The CATCH-UP intervention may contribute to increased rates of insurance coverage, leading to improved cancer screening and prevention rates in community health care settings, and general recommended preventive care.

Primary Outcome

Pre- and post-implementation differences in proportion of patients with insurance continuity will be calculated between implementation and control community health centers (?difference-in-differences? analysis). Generalized linear/non-linear mixed models will be used, which offer flexible regression modeling to accommodate different sources of correlations (serial and intra-clinic), categorical and continuous covariates, and fixed and time-dependent covariates.

Interventions

  • OTHER Informational Intervention

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2014-07-01
Est. Completion 2020-06-30
OHSU Knight Cancer Institute

211 total trials

What the finished NCT02355262 record still lists

NCT02355262 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Informational Intervention is the first listed.

NCT02355262 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02355262 about?

NCT02355262 is a clinical study titled "CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers". This randomized research trial studies the Community-based Health Information Technology (HIT) Tools for Cancer Screening and Health Insurance Promotion (CATCH-UP) intervention in increasing cancer screening and prevention care in uninsured patients at community health centers. The CATCH-UP interven...

What is the current status of trial NCT02355262?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2014-07-01. Estimated completion is 2020-06-30.

What interventions are being tested in trial NCT02355262?

The interventions under investigation include: Informational Intervention (OTHER).

Who is sponsoring clinical trial NCT02355262?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02355262, the US trial registry maintained by the National Library of Medicine. NCT02355262 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.